Hanmi Pharm. Co., Ltd.
128940
Rank in Stocks
#4356
A globally active pharmaceutical company, Hanmi Pharm. Co., Ltd. was... A globally active pharmaceutical company, Hanmi Pharm. Co., Ltd. was established in Seoul, South Korea, in 1973. The firm concentrates its efforts on researching and developing medical therapies for a range of health issues, including diabetes, obesity, cancer, autoimmune disorders, and various rare diseases.
Share Price
$279.16
Market Cap
$3.54B
Change (1 day)
-2.37%
Change (1 year)
14.50%
Country
KR
Trade Hanmi Pharm. Co., Ltd. (128940)
Category
Healthcare
EPS for Hanmi Pharm. Co., Ltd. (128940)
EPS as of June 2026 TTM: $13.95
According to Hanmi Pharm. Co., Ltd. latest financial reports and stock price the company's current EPS (TTM) is $13.95. At the end of 2024 the company had a EPS of $6.51 a decrease compared to its 2023 EPS that were of $8.90.
EPS history for Hanmi Pharm. Co., Ltd. from 2010 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $13.95 | 50.68% |
| 2025 | $9.26 | 42.23% |
| 2024 | $6.51 | -26.89% |
| 2023 | $8.90 | 72.34% |
| 2022 | $5.16 | 16.52% |
| 2021 | $4.43 | 412.37% |
| 2020 | $0.87 | -75.08% |
| 2019 | $3.47 | 41.30% |
| 2018 | $2.46 | -47.26% |
| 2017 | $4.66 | 201.92% |
| 2016 | $1.54 | -85.26% |
| 2015 | $10.47 | 310.16% |
| 2014 | $2.55 | -25.22% |
| 2013 | $3.41 | 83.70% |
| 2012 | $1.86 | 1,718.69% |
| 2011 | $0.10 | -109.84% |
| 2010 | $-1.04 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| $0.72 | -94.82% |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -96.01% |
IN
|
